BioAffinity Technologies, Subsidiary Oncoselect Therapeutics, Has Been Granted U.S. Patent Number 11,590,233 Titled “Porphyrin Compounds And Compositions Useful For Treating Cancer”
https://ppubs.uspto.gov/pubwebapp/external.html?q=(11590233).pn